Keywords: جهش های KRAS; Lynch syndrome; MAP syndrome; MUTYH; KRAS mutations
مقالات ISI جهش های KRAS (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Keywords: جهش های KRAS; BATTLE; Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination; BET; bromodomains and extra-terminal domain; CDK; cyclin-dependent kinase; Chk1; checkpoint kinase 1; CI; confidence interval; CUSTOM; Molecular Profiling and Targete
Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
Keywords: جهش های KRAS; Isocitrate dehydrogenase mutations; Non-small cell lung cancer; KRAS mutations; Clear cell change; Next generation sequencing;
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014
Keywords: جهش های KRAS; Colorectal cancer; Genotyping; KRAS mutations; RAS;
Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening
Keywords: جهش های KRAS; Colorectal cancer; KRAS mutations; High resolution melting; Fixation artifacts; Melting threshold; Screening; Predictive biomarker;
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
Keywords: جهش های KRAS; Trametinib; MEK inhibitor; NSCLC; KRAS mutations;
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
Keywords: جهش های KRAS; ALK rearrangements; Crizotinib; EGFR mutations; Erlotinib; KRAS mutations;
Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?
Keywords: جهش های KRAS; Non-small-cell lung cancer; KRAS mutations; Squamous-cell carcinoma;
Significance of EGFR signaling pathway genetic alterations in radically resected non-small cell lung cancers from a Polish cohort. One institutional study
Keywords: جهش های KRAS; NSCLC; Gene copy gain; EGFR mutations; KRAS mutations
KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance
Keywords: جهش های KRAS; Pancreas; Adenocarcinoma; KRAS mutations;
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
Keywords: جهش های KRAS; Afatinib; Cetuximab; Colorectal cancer; KRAS mutations;
KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
Keywords: جهش های KRAS; KRAS mutations; EGFR-targeted therapy; Colorectal cancer (CRC); Non-small-cell lung cancer (NSCLC); Predictive biomarkers; Personalized medicine; Molecular genetics;
Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect
Keywords: جهش های KRAS; EGFR mutation; KRAS mutations; Lung adenocarcinoma; Primary and metastatic non-small cell lung cancer;
The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome
Keywords: جهش های KRAS; KRAS mutations; BRAF mutations; Intrahepatic cholangiocarcinoma
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy
Keywords: جهش های KRAS; Non-small-cell lung cancer; Early progressive disease; Refractory patients; Platinum-based chemotherapy; Sarcomatoid carcinoma; EGFR mutations; KRAS mutations; ALK translocation
KRAS Mutations in Lung Cancer
Keywords: جهش های KRAS; Aadenocarcinoma; Epidermal growth factor receptor; KRAS mutations; Non-small cell lung cancer
A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit From Adjuvant Platinum-Based Chemotherapy in Node-Negative Non–Small Cell Lung Cancer
Keywords: جهش های KRAS; Non–small-cell lung cancer; KRAS mutations; Adjuvant chemotherapy; TNM staging; Tumor size
Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer
Keywords: جهش های KRAS; PI3KCA; EGFR; KRAS mutations; Response to EGFR TKIs; Survival; NSCLC
Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for th
Keywords: جهش های KRAS; Non-small cell lung cancer; EGFR mutations; KRAS mutations
Development of Molecular Biomarkers in Individualized Treatment of Colorectal Cancer
Keywords: جهش های KRAS; Biomarkers; Chemotherapy; Colorectal cancer; KRAS mutations; Targeted therapies
Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
Keywords: جهش های KRAS; Predictive and prognostic value; KRAS mutations; Cetuximab; Metastatic colorectal cancer; Meta-analysis
Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)
Keywords: جهش های KRAS; Non-small cell lung cancer; Advanced stage; Early stage; Whole genome amplification; Low-volume biopsies; KRAS mutations; CMET mutations; EGFR mutations; p53 mutations; Prognosis